Birdwatch Note
2024-01-14 16:46:42 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
False. GSK sold Intepirdine (RVT-101) to Axovant for $5m. It had some benefits in a phase IIb trial. A re-analysis found a larger effect. 1,315 patients enrolled in Phase III trial with the adjunct drug. The results was not replicated. 98% of alzheimers drugs fail. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198803/ https://www.alzforum.org/therapeutics/intepirdine
Written by 3D704A86D481B4C764C4091B936EAA5007E9AA32387C7827989D397417E5A3CB
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1696997415893553278
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1746574570616959105
- noteId - 1746574570616959105
- participantId -
- noteAuthorParticipantId - 3D704A86D481B4C764C4091B936EAA5007E9AA32387C7827989D397417E5A3CB Participant Details
- createdAtMillis - 1705250802078
- tweetId - 1696997415893553278
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- False. GSK sold Intepirdine (RVT-101) to Axovant for $5m. It had some benefits in a phase IIb trial. A re-analysis found a larger effect. 1,315 patients enrolled in Phase III trial with the adjunct drug. The results was not replicated. 98% of alzheimers drugs fail. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198803/ https://www.alzforum.org/therapeutics/intepirdine
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-01-14 16:46:42 UTC (1705250802078) |
2024-01-14 22:17:56 UTC (1705270676737) |
CURRENTLY_RATED_NOT_HELPFUL | 2024-01-16 02:06:06 UTC (1705370766943) |
CURRENTLY_RATED_NOT_HELPFUL | 2024-01-14 22:17:56 UTC (1705270676737) |
CURRENTLY_RATED_NOT_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-01-14 10:56:42 -0600 | Rating Details | |
| 2024-01-15 03:58:05 -0600 | Rating Details | |
| 2024-01-14 11:52:42 -0600 | Rating Details | |
| 2024-01-14 11:38:30 -0600 | Rating Details | |
| 2024-01-24 06:14:57 -0600 | Rating Details | |
| 2024-01-24 04:24:12 -0600 | Rating Details | |
| 2024-04-12 17:37:28 -0500 | Rating Details | |
| 2024-04-08 13:35:19 -0500 | Rating Details | |
| 2024-05-08 20:57:04 -0500 | Rating Details | |
| 2024-06-26 11:41:40 -0500 | Rating Details | |
| 2024-11-05 10:53:23 -0600 | Rating Details | |
| 2024-10-31 13:14:16 -0500 | Rating Details |